Insmed (INSM)
Insmed Earnings Yield: -79.87%
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
INSM Earnings Yield Rankings
| Overall | 3rd percentile | 4158 of 4312 |
| Sector | 7th percentile | 454 of 492 in Healthcare |
| Industry | 7th percentile | 143 of 155 in Biotechnology |
INSM Earnings Yield Range, Past 5 Years
| Minimum | -96.72% | Dec 2011 |
| Maximum | 120.9% | Dec 2009 |
| Average | -8.13% |
About Earnings Yield
Earnings yield is earnings per share from the previous four quarters divided by the share price. It is the reciprocal of the P/E ratio. The earnings yield is quoted as a percentage, which illustrates the percentage of each dollar invested that was earned by the company during the past twelve months.
The earnings yield can be used to compare the earnings of a stock, sector or the whole market against bond yields. Generally, the earnings yields of equities are higher than the yield of risk-free treasury bonds. Financial theorists argue that this difference exists because stock earnings are riskier than bond coupon payments.
If a company has an earnings yield of 64%, investors are purchasing $0.64 of earnings per dollar invested.
Learn More
You may also be interested in these INSM related companies
INSM News
$INSM 200 Day SMA Cross - Price crossed above 200 day SMA (4.0927). Confirmed by volume.
about 18 days ago by TradeIdeasQuant
about 18 days ago by TradeIdeasQuant
Listen to $INSM Q1 2012 earnings call - live at 08:30 AM, ondemand after - http://stks.co/3iQw
about 18 days ago by earningscast
about 18 days ago by earningscast
$insm took a few short here..might crack into the close http://stks.co/3hmM
about 19 days ago by kunal00
about 19 days ago by kunal00
started into small short on $INSM 4.89 will add in the low 5's target 4
about 19 days ago by LincolnList
about 19 days ago by LincolnList
Insmed $INSM Says Clinical Hold on ARIKACE in CF Patients Lifted
about 19 days ago by Street_Insider
about 19 days ago by Street_Insider
$INSM filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3HoE
about 46 days ago by MarketBrief
about 46 days ago by MarketBrief
Listen to $INSM Q4 2011 earnings call - live at 08:30 AM, ondemand after - http://stks.co/2oMs
about 74 days ago by earningscast
about 74 days ago by earningscast
Insmed (INSM) Commences ARIKACE Phase 2 in NTM Lung Disease Patients, Phase 3 in CF Patients w/ Pa
Feb 10, 8:05AM Street Insider
Feb 10, 8:05AM Street Insider
steppin out to meet tax man.....have order waitin on $INSM if it goes low enough
about 123 days ago by highgrowthfinancial
about 123 days ago by highgrowthfinancial
$INSM could of had 3k @$3.74, stubbornly left bid @$3.73...didn't fill 1 share.WTF! finished strong. will take another look tues
about 124 days ago by highgrowthfinancial
about 124 days ago by highgrowthfinancial
Feuerstein: Insmed Remove on Clinical Hold is "OK", But Still A lot of Overhanging Risk
Jan 20, 8:57AM Benzinga
Jan 20, 8:57AM Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| INSM | 2.98 | -0.02 | -0.67% | 74.08M |
| ING | 5.96 | -0.04 | -0.67% | 22.54B |
| INFY | 42.46 | -0.72 | -1.67% | 24.26B |
| IMN | 5.55 | -0.04 | -0.72% | 212.73M |
| IMKTA | 16.11 | +0.32 | +2.03% | 390.99M |
| IMAX | 21.45 | -0.02 | -0.09% | 1.401B |
| KFT | 38.57 | -0.12 | -0.31% | 68.20B |
| KFFB | 8.62 | +0.00 | +0.00% | 66.72M |
| KEY | 7.50 | -0.04 | -0.53% | 7.148B |
| KERX | 1.75 | +0.00 | +0.00% | 124.28M |
